3654 results for «382»

Filter By

3654 results

Drug-coated balloons: a PREVAIL-ing gamechanger in complex PCI

11 Oct 2025 – From AICT-AsiaPCR 2025

Focus on the evolving role of drug-coated balloons (DCB) in complex PCI, extending their use beyond traditional indications to challenging coronary lesions and high-risk patient populations. This session reviews clinical data from the SCAAR Prevail registry and discusses the evidence journey supporting broader advocacy for DCB...

Drug-coated balloons: a PREVAIL-ing gamechanger in complex PCI

AICT-AsiaPCR 2025 Awards ceremony

11 Oct 2025 – From AICT-AsiaPCR 2025

The AICT-AsiaPCR 2025 Awards ceremony celebrates outstanding achievements and innovations in the field of interventional cardiology. This event recognizes the contributions of clinicians and researchers who have advanced cardiovascular care and highlights excellence across various domains within the specialty.

AICT-AsiaPCR 2025 Awards ceremony

AICT-AsiaPCR 2025 Closing ceremony

11 Oct 2025 – From AICT-AsiaPCR 2025

The AICT-AsiaPCR 2025 Closing ceremony marks the culmination of a comprehensive Course, reflecting on key scientific advancements, collaborative achievements, and the shared commitment to advancing cardiovascular medicine and patient care.

AICT-AsiaPCR 2025 Closing ceremony

AICT-AsiaPCR 2025 Opening ceremony

10 Oct 2025 – From AICT-AsiaPCR 2025

The AICT-AsiaPCR 2025 Opening Ceremony marked the commencement of the conference's comprehensive program, setting the stage for cutting-edge discussions and advancements in interventional cardiology across the Asia-Pacific region.

AICT-AsiaPCR 2025 Opening ceremony

CTO techniques and strategies

11 Oct 2025 – From AICT-AsiaPCR 2025

Explore advanced techniques and strategic approaches in chronic total occlusion (CTO) interventions, including novel methods for severely calcified lesions, bifurcation management, and complex anatomies such as right main CTOs. The session highlights epicardial collateral navigation, device synergy for calcified coronary disease, indigenous perforation techniques, and ultra-low...

Retrievals, foreign bodies and entrapments

11 Oct 2025 – From AICT-AsiaPCR 2025

This session addresses the complexities of retrievals, foreign bodies, and entrapments in interventional cardiology. It presents clinical cases illustrating percutaneous retrieval techniques, management of catheter fractures, iatrogenic dissections, and innovative solutions for challenging scenarios. Emphasis is placed on precision, prevention strategies, and effective problem-solving to mitigate...

Coronary complications and rescue cases

11 Oct 2025 – From AICT-AsiaPCR 2025

This compelling session addresses complex coronary complications and rescue cases encountered in the cath lab. Through a series of challenging case studies, it highlights critical scenarios such as silent coronary artery threats, procedural nightmares, coronary perforations, and innovative rescue strategies that transform high-risk situations into successful...

Coronary complications and rescue cases

TAVI and aortic valve procedures

11 Oct 2025 – From AICT-AsiaPCR 2025

Focusing on transcatheter aortic valve interventions, this session covers a broad spectrum of complex cases including emergent TAV-in-SAV procedures, management of severely calcified bicuspid valves, zero-contrast TAVI techniques, and strategies for hostile anatomies. It provides valuable insights into procedural planning and follow-up to optimize patient care...

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

POPular PAUSE TAVI - Continuation or interruption of oral anticoagulation during TAVI?

02 Sep 2024

Luis Ortega-Paz provides his take on the POPular PAUSE TAVI trial presented by Dirk Jan van Ginkel at the ESC Congress 2024 in London.

Luis Ortega-Paz

Author

Luis Ortega-Paz
POPular PAUSE TAVI

Best of #AHA21 Scientific Sessions: coronary and valvular heart disease trials

14 Nov 2021

Vijay Kunadian provides summaries of study designs and findings in Interventional Cardiology released at the 2021 virtual edition of the American Heart Association Congress. View an infographic of the AVATAR late-breaking trial by Ali Nazmi Calik.

Vijay Kunadian

Author

Vijay Kunadian
Best of #AHA21 Scientific sessions

Evidence base: current data on TAVI durability and long-term outcomes

18 Jun 2026

This article reviews the current evidence on TAVI durability, focusing on long-term outcomes, device-specific considerations, and the implications for lifetime management strategies.

Tanja Rudolph

Author

Tanja Rudolph
Georges El Hachem

Author

Georges El Hachem
Evidence base: current data on durability

ESC/EACTS Valvular Heart Disease Guidelines 2021: updates from the 2017 Guidelines

29 Aug 2021

There has been significant expansion in the field of structural heart diseases in the last couple of years, generating an extensive body of evidence and warranting an update to the 2017 Guidelines. Mirvat Alasnag provides an analysis of the updates included in this new document - a joint...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag

Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)

30 Oct 2024

Ali Nazmi Calik provides his take on the EVOLVED trial presented by Marc Dweck at TCT 2024 in Washington.

Ali Nazmi Calik

Author

Ali Nazmi Calik
Early intervention in patients with asymptomatic severe aortic stenosis and left ventricular myocardial fibrosis (EVOLVED)
Didn’t find what you were looking for?